SARS and Avian Flu Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SARS and Avian Flu

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Maurice Winn who wrote (2706)	10/15/2005 4:42:13 AM
From: Elroy Jetson	Read Replies (2) of 4232

The problem with Passive Immune Therapy (infusing the IGG from a previously infected person) is that its not terribly effective • • • • • • in spite of the high cost and frequent auto-immune side-effects. The most effective immune response is Th-1 the cellular response. This is the system which is primed by vaccinations or activated by interferon-alpha. The Th-2 antibody system is responsible for post infection clean-up, and can help trigger a re-activation of the Th-1 system if the pathogen re-emerges. .

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next